FDA Approved: SPIRONOLACTONE — Supplemental Application (Oxford Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for spironolactone by Oxford Pharmaceuticals, LLC. The approval allows continued marketing of the generic product under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hyperaldosteronism
• Hypertension
• Liver Cirrhosis
• Nephrotic Syndrome

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

SUPPL AP for SPIRONOLACTONE (SPIRONOLACTONE)